Abstract: A system and method of loading a programmable counter includes storing a first digital divide value in a register. The first digital divide value is then loaded from the register to a programmable counter. The method further includes writing a second digital divide value to the register at a time responsive to a time remaining to complete a counting cycle of the programmable counter.

Abstract: Disclosed is a circuit for encoding code phase modulated (CPM) signals, including a code storage device storing one or more PN codes, a counter, and a multiplexer coupled to the code storage device and the counter, the multiplexer to provide an encoded CPM sequence using the one or more reference codes.

Abstract: This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

Abstract: Disclosed is a circuit for decoding code phase modulated (CPM) signals, including a pseudo-noise (PN) code storage device, storing one or more reference PN codes, a peak detector having an output with decoded CPM data, and a correlation block, including a correlation multiplexer, a plurality of shift registers coupled to the correlation multiplexer, a selection circuit coupled to the plurality of shift registers, and a correlator coupled to the code storage device and correlation multiplexer. Also disclosed is a method for operating the circuit in two operating modes for decoding CPM signals.

Abstract: A spread spectrum slip time encoding scheme encodes data values with one or more Pseudo Noise (PN) codes and generates a corresponding PN encoded data stream. Other data values are encoded into the PN encoded data stream by varying a slip time between the PN-encoded data values.

Abstract: A polymer for use in an optical device comprising a first, optionally substituted, repeat unit of formula and a second, optionally substituted, repeat unit of formula wherein each Ar and Ar? is the same or different and comprises an optionally substituted aryl or heteroaryl group and optionally a third, optionally substituted, repeat unit in a molar ratio of no greater than 5%, the third repeat unit having a formula —Ar—N(Ar)—Ar— and having a single nitrogen atom in its backbone.

Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

Abstract: An organic light emitting device having a phase-separated light-emissive layer comprising: a charge transport phase comprising a charge transport material; and an emitting phase, the emitting phase comprising a plurality of discrete emissive domains dispersed in the charge transport phase, each emitting domain comprising a host material and one or more metal complexes for emitting light by phosphorescence; wherein the charge transport material has a T1 energy level lower than the T1 energy level of the metal complexes and the host material has a T1 energy level higher than the T1 energy level of the metal complexes.

Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

Abstract: This invention provides peptides that act as selective NPY2 receptor agonists in vitro and are efficacious in vivo to reduce food intake. The invention is a peptide selected from a specific group of derivatized NPY-related peptides, or functional equivalents thereof. The invention is also directed to a method of treating a metabolic disease in a mammal comprising administering a therapeutically effective amount of the peptides to said mammal to reduce food intake and body weight.

Abstract: A method of transmitting communications codes is used in spread spectrum communications systems. The method includes transmitting a first pseudo-noise code, and transmitting a second pseudo-noise code, wherein the second pseudo-noise code is a time-reversed version of the first pseudo-noise code. A device includes a first shift register to store a first code and a second register to store a second code in a time-reversed version. A comparison circuit then compares the two codes and a result is output.

Abstract: This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

Abstract: An electroluminescent device comprising:—a first electrode for injection of positive charge carriers;—a second electrode for injection of negative charge carriers; and—an electroluminescent layer located between the first and second electrodes comprising a host material and a metal complex, wherein the host material comprises a polymer having a first repeat unit of formula (I): wherein each Ar is the same or different and independently represents an optionally substituted aryl or heteroaryl and any two Ar groups may be directly linked by a single bond.

Abstract: This invention relates to certain biphenyl-4-yl carbonylamino acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

Abstract: The present invention relates to the use of self-assembled monolayers with mixtures of conductive oligomers and insulators to detect target analytes.

Abstract: The invention is directed to a method of analyzing a plurality of biochips. In particular, the method includes inserting a first biochip in to a first station of an analysis device, inserting a second biochip into a second station of the analysis device, wherein each of the first and second biochips comprise a substrate that includes an array of detection electrodes, each including a different capture binding ligand, a different target analyte, and a label, and a plurality of electrical contacts, detecting current as an indication of the presence of the labels on the first biochip and detecting current as an indication of the presence of the labels on the second biochip.

Abstract: The present invention relates to compositions comprising a structured benefit agent pre-mix or delivery vehicle comprising benefit agent structured with crystalline materials, as defined, which when separately prepared and combined after preparation, provides enhanced delivery of benefit agent from a personal product bar carrying composition into which the premix is added. The use of structured benefit agent also enhances delivery of separate benefit agents in the premix (which may or may not be structured) and of separate benefit agents added separately from the premix.

Abstract: Compounds are provided having the formula: wherein R1, R2, R2?, R3, R3?, R4, R4? R5, X, Y and Z are as defined herein.

Abstract: A preferred contact group centric interface for a communication device can be used to facilitate communications by a user. The user interface can be arranged to activate from a user's “home page” on the display, from an idle screen that is accessed after a timeout period expires, or any other appropriate mechanism that activates the preferred contact group centric experience. A user selects the preferred contact group from among an array of the user's contacts. Once the contact group is configured, a minimal number of navigation/selection features is necessary to activate any number of communication modes available to the contacts. The contact group is configured such that simple and quick navigation between the contact members is achieved. The contact group can be presented in 2D and 3D arrangements, in any number of list or geometric configurations. A pricing plan can optionally be tied to each member of the contact group.